Money · Lobbying reports · 119th Congress
H.R. 1414
13 saved lobbying reports name H.R. 1414.
13 reports
Confirmed from the official recordSenate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Lobbying Disclosure Act reports, LDA.gov. This copy was read October 8, 2026 at 1:29 AM Eastern.
Reports that name this bill
The amount is what the report gives for the whole quarter: everything the registrant did for that client, all issues together. A linked name opens that organization’s page on this site.
| Registrant | Client | Amount for the whole quarter | Quarter | Report |
|---|---|---|---|---|
| THE WASHINGTON TAX & PUBLIC POLICY GROUP | MODERNATX, INC. | $30,000.00reported as income | April to June 2026 | Open the report |
| HEALTHCARE INSTITUTE OF NEW JERSEY | HEALTHCARE INSTITUTE OF NEW JERSEY | $47,670.00reported as expenses | April to June 2026 | Open the report |
| VERTEX PHARMACEUTICALS INCORPORATED | VERTEX PHARMACEUTICALS INCORPORATED | $1,200,000.00reported as expenses | April to June 2026 | Open the report |
| RARE DISEASE COMPANY COALITION | RARE DISEASE COMPANY COALITION | $70,000.00reported as expenses | April to June 2026 | Open the report |
| EVERYLIFE FOUNDATION FOR RARE DISEASES | EVERYLIFE FOUNDATION FOR RARE DISEASES | $40,000.00reported as expenses | April to June 2026 | Open the report |
| IONIS PHARMACEUTICALS, INC. | IONIS PHARMACEUTICALS, INC. | $150,000.00reported as expenses | April to June 2026 | Open the report |
| TRAVERE THERAPEUTICS | TRAVERE THERAPEUTICS | $140,000.00reported as expenses | April to June 2026 | Open the report |
| HARMONY BIOSCIENCES | HARMONY BIOSCIENCES | $180,000.00reported as expenses | April to June 2026 | Open the report |
| PTC THERAPEUTICS, INC. | PTC THERAPEUTICS, INC. | $170,000.00reported as expenses | April to June 2026 | Open the report |
| ACADIA PHARMACEUTICALS | ACADIA PHARMACEUTICALS | $700,000.00reported as expenses | April to June 2026 | Open the report |
| ASTRAZENECA PHARMACEUTICALS LP | ASTRAZENECA PHARMACEUTICALS LP | $1,680,000.00reported as expenses | April to June 2026 | Open the report |
| SOLENO THERAPEUTICS, INC. | SOLENO THERAPEUTICS, INC. | $70,000.00reported as expenses | April to June 2026 | Open the report |
| ALSTON & BIRD LLP | TRAVERE THERAPEUTICS | $70,000.00reported as income | April to June 2026 | Open the report |